Ligand Pharma (LGND) to Restate FY11, Q112, Q212 Financials

November 5, 2012 4:02 PM

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced plans to restate financial statements for 2011 and the first two quarters of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found